Ocean Biomedical CEO Elizabeth Ng (L) and Aesther CEO Suren Ajjarapu
After ditching electric vehicle parts maker, a SPAC chooses a Brown spinout that had tested the IPO waters
While the market remains difficult to navigate, the latest SPAC merger shows that biotechs and blank checks are still willing to brace the choppy waters …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.